Across
- 2. Integrated addendum to ICH E6 GCP emphasizing risk-based quality management. (7)
- 4. Plan for pharmacovigilance and risk minimization. (3)
- 7. Attributes essential for reliable, interpretable results. (3)
- 8. Remote oversight of accumulating trial data as part of risk-based monitoring. (17)
- 9. Factors Critical-to-Quality(3)
- 10. Any departure from the approved clinical trial protocol. (17)
Down
- 1. FDA regulation for trustworthy electronic records and signatures. (11)
- 3. Medical Dictionary for Regulatory Activities (standardized terminology). (6)
- 5. Actions to reduce likelihood and/or impact of trial risks. (10)
- 6. CDISC Study Data Tabulation Model for regulatory submissions. (4)
